Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
The Oncology Institute, Inc. (TOI)
USD5.79
-0.49 (-7.80%)
US NASDAQ Healthcare Medical - Care Facilities
Address
18000 Studebaker Road 90703
Cerritos, CA, US
Cerritos, CA, US
CEO
Daniel Virnich
Website
theoncologyinstitute.com
IPO
2020-06-04
CIK 1799191 ISIN US68236X1000
Also trades on
NASDAQ Capital Market · TOI (USD)
NASDAQ Capital Market · TOIIW (USD)
NASDAQ Global Select · DFPHU (USD)
New York Stock Exchange · DFPHW (USD)
Description
The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.
News Sentiment (7d)
3 articles
- 2 More Stocks to Buy for the AI Convergence InvestorPlace
- Best Cheap Stocks Under $10 to Buy Now in July Zacks Investment Research
- The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity GlobeNewsWire
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| DFP Healthcare Acquisitions Corp. | DFPHU | 2021-07-23 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD5.79
-0.49 (-7.80%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.39
Float Shares
48.84M
Free Float %
49.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.25% | +6.65% | +30.19% | +68.49% | +16.91% | +12.64% | +57.25% | +709.61% | -59.78% | -58.66% | -58.66% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (5 ratings, all time)
Buy
Price Targets & DCF
Current price
5.79
Low
5.00
-13.6%
Consensus
5.00
-13.6%
Median
5.00
-13.6%
High
5.00
-13.6%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
5.00
-13.6%
|
| All Time | 3 |
7.00
+20.9%
|
Quality scores
Altman Z-Score
1.98
Grey zone
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+27.8% ★ Q1'26: +41.2% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+23.9% ★ Q1'26: +90.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-8.4% Q1'26: -2.2% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%-7.2% Q1'26: -4.4% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%-66.3% Q1'26: +128.2% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+1,131.1% Q1'26: +1,220.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×-3.56× Q1'26: -1.34× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
252.48M
est: 245.76M (+2.7%)
|
324.24M
est: 361.07M (-10.2%)
|
393.41M
est: 414.70M (-5.1%)
|
502.73M
est: 500.58M (+0.4%)
|
656.10M
645.95M – 666.24M
+31.1% YoY
|
822.26M
777.05M – 867.47M
+25.3% YoY
|
| EBITDA |
-67.60M
est: -41.25M (-63.9%)
|
-54.28M
est: -60.44M (+10.2%)
|
-53.83M
est: -69.42M (+22.5%)
|
-29.14M
est: -83.80M (+65.2%)
|
-109.83M
-111.53M – -108.13M
-31.1% YoY
|
-137.65M
-145.22M – -130.08M
-25.3% YoY
|
| EBIT |
-72.01M
est: -45.43M (-58.5%)
|
-60.15M
est: -66.35M (+9.3%)
|
-60.12M
est: -76.21M (+21.1%)
|
-36.08M
est: -91.99M (+60.8%)
|
-120.57M
-122.43M – -118.71M
-31.1% YoY
|
-151.11M
-159.41M – -142.80M
-25.3% YoY
|
| Net Income |
152.0K
est: -21.23M (+100.7%)
|
-83.07M
|
-64.66M
est: -333.45M (+80.6%)
|
-60.61M
est: -542.79M (+88.8%)
|
-143.29M
-143.60M – -142.98M
+73.6% YoY
|
-69.47M
-72.66M – -66.28M
+51.5% YoY
|
| SGA |
—
est: 10.98M (-100.0%)
|
—
est: 15.16M (-100.0%)
|
—
est: 17.42M (-100.0%)
|
105.57M
est: 21.02M (+402.1%)
|
27.56M
27.13M – 27.98M
+31.1% YoY
|
34.54M
32.64M – 36.43M
+25.3% YoY
|
| EPS |
0.00
est: -0.28 (+100.3%)
|
-0.92
|
-0.71
est: -0.36 (-97.2%)
|
-0.54
est: -0.59 (+8.1%)
|
-0.16
-0.16 – -0.15
+73.6% YoY
|
-0.08
-0.08 – -0.07
+51.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-15.01M
OE per share TTM
-0.02
Owner's Yield
-0.36%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
7.5%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
23
Total invested
9.77M
Insider transactions (90d)
2
Beneficial owners (>5%)
32
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Havencrest Healthcare Partners GP, LLC | 15.66M | 21.00% | — | 15.66M | — | 15.66M | OO | — | 2022-07-11 | ↗ |
| 2 | Havencrest Healthcare Partners, L.P. | 15.66M | 21.00% | — | 15.66M | — | 15.66M | PN | — | 2022-07-11 | ↗ |
| 3 | TOI HC I, LLC | 15.66M | 21.00% | — | 15.66M | — | 15.66M | OO | — | 2022-07-11 | ↗ |
| 4 | Growth I GP LLC | 13.70M | 18.70% | — | 13.70M | — | 10.00 | OO | Delaware | 2021-11-22 | ↗ |
| 5 | Growth I LP | 13.70M | 18.70% | — | 13.70M | — | 10.00 | PN | Delaware | 2021-11-22 | ↗ |
| 6 | M33 Growth I GP LLC | 13.70M | 18.60% | — | 13.70M | — | 10.00 | OO | Delaware | 2022-09-26 | ↗ |
| 7 | M33 Growth I LP | 13.70M | 18.60% | — | 13.70M | — | 10.00 | PN | Delaware | 2022-09-26 | ↗ |
| 8 | Abigail P. Johnson | 12.00M | 12.47% | — | — | 12.00M | — | IN | Delaware | 2021-12-10 | ↗ |
| 9 | FMR LLC | 12.00M | 12.47% | 2.16M | — | 12.00M | — | HC | Delaware | 2021-12-10 | ↗ |
| 10 | Deerfield Management Company, L.P. | 10.46M | 36.38% | — | 10.46M | — | 10.00 | PN | Delaware | 2020-03-23 | ↗ |
| 11 | James E. Flynn | 10.46M | 36.38% | — | 10.46M | — | 10.00 | IN | United States of America | 2020-03-23 | ↗ |
| 12 | Richy Agajanian | 8.15M | 10.93% | 7.64M | 506.9K | 7.64M | — | IN | United States | 2021-11-26 | ↗ |
| 13 | Deerfield Mgmt IV, L.P. | 7.86M | 27.34% | — | 7.86M | — | 10.00 | PN | Delaware | 2020-03-23 | ↗ |
| 14 | Deerfield Partners, L.P. | 7.86M | 27.34% | — | 7.86M | — | 10.00 | PN | Delaware | 2020-03-23 | ↗ |
| 15 | Deerfield Private Design Fund IV, L.P. | 7.86M | 27.34% | — | 7.86M | — | 10.00 | PN | Delaware | 2020-03-23 | ↗ |
| 16 | Jimmy Holdings, Inc. | 7.64M | 10.20% | 7.64M | — | 7.64M | — | CO | United States | 2021-11-26 | ↗ |
| 17 | DFP Sponsor LLP | 5.36M | 18.64% | — | 5.36M | — | 10.00 | OO | Delaware | 2020-03-23 | ↗ |
| 18 | Daniel Murillo | 4.63M | 6.20% | — | 4.63M | — | — | IN | Delaware | 2021-11-24 | ↗ |
| 19 | FOG Ventures Investments, LLC | 4.63M | 6.20% | — | 4.63M | — | — | OO | Delaware | 2021-11-24 | ↗ |
| 20 | M, LLC | 1.55M | 2.10% | 1.55M | — | 1.55M | 10.00 | OO | Delaware | 2021-11-22 | ↗ |
| 21 | TOI M, LLC | 1.55M | 2.10% | 1.55M | — | 1.55M | 10.00 | OO | Delaware | 2022-09-26 | ↗ |
| 22 | Lawrence M. Feis | 1.46M | 6.35% | 1.46M | — | 1.46M | — | IN | Illinois | 2021-11-09 | ↗ |
| 23 | Anthony A. Yoseloff | 1.44M | 6.26% | — | 1.44M | — | — | IN | — | 2021-02-11 | ↗ |
| 24 | Davidson Kempner Capital Management LP | 1.44M | 6.26% | — | 1.44M | — | — | PN | — | 2021-02-11 | ↗ |
| 25 | Davidson Kempner International, Ltd. | 605.0K | 2.63% | — | 605.0K | — | — | CO | — | 2021-02-11 | ↗ |
| 26 | Davidson Kempner Institutional Partners, L.P. | 566.6K | 2.46% | — | 566.6K | — | — | PN | — | 2021-02-11 | ↗ |
| 27 | Davidson Kempner Partners | 225.0K | 1.11% | — | 225.0K | — | — | PN | — | 2021-02-11 | ↗ |
| 28 | Park West Asset Management LLC | 62.2K | 0.30% | — | 62.2K | — | — | IA | Delaware | 2022-02-14 | ↗ |
| 29 | Peter S. Park | 62.2K | 0.30% | — | 62.2K | — | — | IN | Delaware | 2022-02-14 | ↗ |
| 30 | Park West Investors Master Fund, Limited | 56.7K | 0.20% | — | 56.7K | — | — | CO | Delaware | 2022-02-14 | ↗ |
| 31 | M. H. Davidson & Co. | 13.5K | 0.06% | — | 13.5K | — | — | PN | — | 2021-02-11 | ↗ |
| 32 | 2. | 10.00 | 6.30% | — | 1.46M | — | — | IA, HC, OO | Delaware | 2021-08-23 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
23
-99 vs prev Q
New positions
4
Closed positions
97
Increased
12
Reduced
5
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | NVERSES CAPITAL, LLC | 31.6K +31.6K (+100.0%) | 112.48M +112.5M (+100.0%) | 0.00% +0.003 pp | 0.25% +0.252 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 2 | VANGUARD GROUP INC | 4.75M +203.4K (+4.5%) | 16.91M +1.0M (+6.6%) | 0.49% -0.001 pp | 0.00% +0.000 pp | USD3.75 -5.1% | 17 qtrs — |
| 3 | BLACKROCK, INC. | 3.91M +470.5K (+13.7%) | 13.90M +1.9M (+16.0%) | 0.40% +0.032 pp | 0.00% +0.000 pp | USD2.17 +64.1% | 6 qtrs — |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.36M +— (+0.0%) | 11.96M +235.2K (+2.0%) | 0.34% -0.016 pp | 0.15% -0.026 pp | USD9.63 -63.0% | 17 qtrs — |
| 5 | CENTERBOOK PARTNERS LP | 3.03M +324.7K (+12.0%) | 10.78M +1.3M (+14.3%) | 0.31% +0.021 pp | 0.53% +0.061 pp | USD3.16 +12.7% | 3 qtrs — |
| 6 | KANEN WEALTH MANAGEMENT LLC | 2.98M +1.1M (+61.6%) | 10.71M +4.3M (+66.8%) | 0.31% +0.108 pp | 3.25% +1.106 pp | USD3.52 +1.1% | 2 qtrs — |
| 7 | BALYASNY ASSET MANAGEMENT L.P. | 2.52M +100.0 (+0.0%) | 8.97M +176.6K (+2.0%) | 0.26% -0.012 pp | 0.01% +0.000 pp | USD1.69 +110.7% | 10 qtrs — |
| 8 | JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 2.46M +2.3M (+1,104.3%) | 8.76M +8.0M (+1,128.5%) | 0.25% +0.230 pp | 6.53% +5.958 pp | USD3.37 +5.6% | 4 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.57M +168.5K (+12.0%) | 5.59M +698.8K (+14.3%) | 0.16% +0.011 pp | 0.00% +0.000 pp | USD2.72 +30.9% | 17 qtrs — |
| 10 | WEXFORD CAPITAL LP | 1.53M -37.6K (-2.4%) | 5.46M -23.9K (-0.4%) | 0.16% -0.011 pp | 1.05% +0.265 pp | USD2.46 +44.7% | 3 qtrs — |
| 11 | STATE STREET CORP | 1.35M +221.6K (+19.6%) | 4.81M +868.0K (+22.0%) | 0.14% +0.017 pp | 0.00% +0.000 pp | USD2.92 +21.9% | 16 qtrs — |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 721.9K -28.6K (-3.8%) | 2.57M -49.3K (-1.9%) | 0.07% -0.007 pp | 0.00% +0.001 pp | USD2.21 +61.1% | 12 qtrs — |
| 13 | B. RILEY FINANCIAL, INC. | 663.4K -148.2K (-18.3%) | 2.36M -470.7K (-16.6%) | 0.07% -0.019 pp | 1.01% -0.906 pp | USD2.50 +42.4% | 4 qtrs — |
| 14 | GOLDMAN SACHS GROUP INC | 570.4K -111.2K (-16.3%) | 2.03M -348.2K (-14.6%) | 0.06% -0.015 pp | 0.00% +0.000 pp | USD3.01 +18.3% | 4 qtrs — |
| 15 | NORTHERN TRUST CORP | 499.2K +34.6K (+7.4%) | 1.78M +155.5K (+9.6%) | 0.05% +0.001 pp | 0.00% +0.000 pp | USD2.54 +40.2% | 16 qtrs — |
| 16 | CITADEL ADVISORS LLC | 450.3K +369.9K (+460.1%) | 1.60M +1.3M (+471.3%) | 0.05% +0.038 pp | 0.00% +0.000 pp | USD3.55 +0.3% | 2 qtrs — |
| 17 | MASSAR CAPITAL MANAGEMENT, LP | 400.0K +— (+0.0%) | 1.42M +28.0K (+2.0%) | 0.04% -0.002 pp | 0.15% -0.031 pp | USD1.82 +95.6% | 4 qtrs — |
| 18 | JPMORGAN CHASE & CO | 386.8K +362.3K (+1,483.3%) | 1.38M +1.3M (+1,515.0%) | 0.04% +0.037 pp | 0.00% +0.000 pp | USD3.46 +2.9% | 17 qtrs — |
| 19 | FOURWORLD CAPITAL MANAGEMENT LLC | 382.7K +24.7K (+6.9%) | 1.36M +113.0K (+9.0%) | 0.04% +0.001 pp | 1.10% -0.868 pp | USD1.83 +94.5% | 8 qtrs — |
| 20 | FREEGULLIVER LLC | 355.7K +145.7K (+69.4%) | 1.27M +533.3K (+72.8%) | 0.04% +0.014 pp | 0.47% +0.139 pp | USD1.90 +87.4% | 9 qtrs — |
| 21 | JANE STREET GROUP, LLC | 326.0K +194.1K (+147.2%) | 1.16M +700.2K (+152.1%) | 0.03% +0.019 pp | 0.00% +0.000 pp | USD3.53 +0.8% | 2 qtrs — |
| 22 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 295.2K +295.2K (+100.0%) | 1.05M +1.1M (+100.0%) | 0.03% +0.030 pp | 0.00% +0.000 pp | USD3.56 +0.0% | 7 qtrs — |
| 23 | UBS GROUP AG | 287.7K -768.2K (-72.8%) | 1.02M -2.7M (-72.2%) | 0.03% -0.084 pp | 0.00% 0.000 pp | USD2.90 +22.8% | 5 qtrs — |
| 24 | LPL FINANCIAL LLC | 270.9K +3.9K (+1.5%) | 964.4K +32.6K (+3.5%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD3.49 +2.0% | 2 qtrs — |
| 25 | TWO SIGMA INVESTMENTS, LP | 262.1K -16.9K (-6.1%) | 932.9K -40.7K (-4.2%) | 0.03% -0.003 pp | 0.00% 0.000 pp | USD2.05 +73.7% | 3 qtrs — |
| 26 | MAVEN SECURITIES LTD | 251.1K +151.1K (+151.1%) | 894.0K +545.0K (+156.2%) | 0.03% +0.015 pp | 0.02% +0.011 pp | USD3.53 +0.8% | 2 qtrs — |
| 27 | MOUNT LUCAS MANAGEMENT LP | 250.0K +89.5K (+55.8%) | 890.0K +329.9K (+58.9%) | 0.03% +0.008 pp | 0.36% +0.126 pp | USD3.07 +16.0% | 3 qtrs — |
| 28 | MORGAN STANLEY | 222.1K +131.0K (+144.0%) | 790.5K +472.9K (+148.9%) | 0.02% +0.013 pp | 0.00% +0.000 pp | USD2.91 +22.3% | 17 qtrs — |
| 29 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 208.3K +20.7K (+11.1%) | 741.4K +86.9K (+13.3%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD2.48 +43.5% | 3 qtrs — |
| 30 | — | 201.1K +201.1K (+100.0%) | 715.9K +715.9K (+100.0%) | 0.02% +0.021 pp | 0.89% +0.889 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 31 | TIFF ADVISORY SERVICES INC | 195.6K -661.1K (-77.2%) | 696.2K -2.3M (-76.7%) | 0.02% -0.072 pp | 0.12% -0.503 pp | USD0.79 +350.6% | 10 qtrs — |
| 32 | MILLENNIUM MANAGEMENT LLC | 193.1K -757.9K (-79.7%) | 687.6K -2.6M (-79.3%) | 0.02% -0.082 pp | 0.00% -0.001 pp | USD2.88 +23.6% | 3 qtrs — |
| 33 | EAM INVESTORS, LLC | 182.5K +— (+0.0%) | 649.7K +12.8K (+2.0%) | 0.02% -0.001 pp | 0.07% -0.001 pp | USD2.05 +73.7% | 3 qtrs — |
| 34 | MARSHALL WACE, LLP | 180.3K +155.1K (+616.5%) | 641.9K +554.0K (+630.9%) | 0.02% +0.016 pp | 0.00% +0.001 pp | USD3.35 +6.3% | 3 qtrs — |
| 35 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 155.7K +155.7K (+100.0%) | 554.4K +554.4K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.000 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 36 | BANK OF NEW YORK MELLON CORP | 138.8K +6.9K (+5.3%) | 494.3K +33.9K (+7.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.60 +122.5% | 9 qtrs — |
| 37 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 117.3K +2.1K (+1.8%) | 417.7K +15.5K (+3.8%) | 0.01% 0.000 pp | 0.00% -0.001 pp | USD3.49 +2.0% | 2 qtrs — |
| 38 | SEI INVESTMENTS CO | 111.6K +111.6K (+100.0%) | 397.1K +397.1K (+100.0%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 39 | STATE OF WYOMING | 106.7K +43.7K (+69.4%) | 379.8K +159.9K (+72.8%) | 0.01% +0.004 pp | 0.04% +0.017 pp | USD3.28 +8.5% | 3 qtrs — |
| 40 | BARCLAYS PLC | 106.5K +20.6K (+24.0%) | 379.0K +79.4K (+26.5%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD2.34 +52.1% | 3 qtrs — |
| 41 | KINGSWOOD WEALTH ADVISORS, LLC | 98.7K +21.1K (+27.2%) | 351.4K +80.5K (+29.7%) | 0.01% +0.002 pp | 0.02% +0.001 pp | USD2.57 +38.5% | 3 qtrs — |
| 42 | HIGHTOWER ADVISORS, LLC | 85.9K +4.5K (+5.5%) | 305.6K +21.7K (+7.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD0.90 +295.6% | 8 qtrs — |
| 43 | BOOTHBAY FUND MANAGEMENT, LLC | 85.2K -162.7K (-65.6%) | 303.4K -561.7K (-64.9%) | 0.01% -0.018 pp | 0.00% -0.008 pp | USD3.49 +2.0% | 2 qtrs — |
| 44 | WELLS FARGO & COMPANY/MN | 83.6K +45.2K (+117.9%) | 297.6K +163.7K (+122.3%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD3.00 +18.7% | 3 qtrs — |
| 45 | LEE FINANCIAL CO | 81.4K +— (+0.0%) | 289.6K +5.7K (+2.0%) | 0.01% 0.000 pp | 0.04% +0.004 pp | USD0.75 +374.7% | 8 qtrs — |
| 46 | CREATIVE PLANNING | 78.6K +78.6K (+100.0%) | 279.9K +279.9K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 47 | NUVEEN, LLC | 76.7K +— (+0.0%) | 273.0K +5.4K (+2.0%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD2.05 +73.7% | 3 qtrs — |
| 48 | RHUMBLINE ADVISERS | 74.6K -8.8K (-10.5%) | 265.5K -25.5K (-8.8%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.05 +73.7% | 3 qtrs — |
| 49 | GSA CAPITAL PARTNERS LLP | 70.7K +70.7K (+100.0%) | 252.0K +252.0K (+100.0%) | 0.01% +0.007 pp | 0.02% +0.022 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 50 | FIELDER CAPITAL GROUP LLC | 70.2K +— (+0.0%) | 249.9K +4.9K (+2.0%) | 0.01% 0.000 pp | 0.05% -0.003 pp | USD2.04 +74.5% | 9 qtrs — |
| 51 | WEALTHSHIELD PARTNERS, LLC | 70.2K +— (+0.0%) | 249.7K +4.9K (+2.0%) | 0.01% 0.000 pp | 0.03% 0.000 pp | USD1.14 +212.3% | 4 qtrs — |
| 52 | POINT72 ASSET MANAGEMENT, L.P. | 69.3K +69.3K (+100.0%) | 246.6K +246.6K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 53 | PRIVATE ADVISOR GROUP, LLC | 62.2K -6.7K (-9.7%) | 221.5K -19.0K (-7.9%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD3.49 +2.0% | 2 qtrs — |
| 54 | GROUP ONE TRADING, L.P. | 62.1K +62.1K (+100.0%) | 221.2K +221.2K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 55 | SQUAREPOINT OPS LLC | 61.8K -80.8K (-56.7%) | 219.9K -277.6K (-55.8%) | 0.01% -0.009 pp | 0.00% 0.000 pp | USD3.49 +2.0% | 2 qtrs — |
| 56 | ALLIANCEBERNSTEIN L.P. | 61.6K +— (+0.0%) | 219.3K +4.3K (+2.0%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD2.60 +36.9% | 3 qtrs — |
| 57 | CAPTION MANAGEMENT, LLC | 50.1K +50.1K (+100.0%) | 178.4K +178.4K (+100.0%) | 0.01% +0.005 pp | 0.00% +0.001 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 58 | AQR CAPITAL MANAGEMENT LLC | 48.1K +4.0K (+9.1%) | 171.1K +17.4K (+11.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.50 +1.7% | 2 qtrs — |
| 59 | DEUTSCHE BANK AG\ | 47.8K -40.6K (-45.9%) | 170.3K -138.5K (-44.8%) | 0.00% -0.005 pp | 0.00% +0.000 pp | USD3.46 +2.9% | 3 qtrs — |
| 60 | INVESCO LTD. | 47.0K +8.4K (+21.8%) | 167.4K +32.7K (+24.3%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.32 +53.4% | 3 qtrs — |
| 61 | XTX TOPCO LTD | 46.5K +46.5K (+100.0%) | 165.6K +165.6K (+100.0%) | 0.00% +0.005 pp | 0.00% +0.004 pp | USD3.56 +0.0% | 10 qtrs — |
| 62 | BANK OF AMERICA CORP /DE/ | 46.4K -5.3K (-10.2%) | 165.4K -15.2K (-8.4%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.77 +28.5% | 16 qtrs — |
| 63 | METLIFE INVESTMENT MANAGEMENT, LLC | 40.5K +18.8K (+87.0%) | 144.0K +68.5K (+90.7%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD2.75 +29.5% | 3 qtrs — |
| 64 | PRICE T ROWE ASSOCIATES INC /MD/ | 38.0K +8.2K (+27.7%) | 136.0K +32.0K (+30.8%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.38 +49.6% | 3 qtrs — |
| 65 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 31.7K +4.5K (+16.6%) | 112.7K +18.0K (+19.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.27 +56.8% | 3 qtrs — |
| 66 | LARSON FINANCIAL GROUP LLC | 31.5K +5.2K (+19.7%) | 112.0K +20.3K (+22.1%) | 0.00% +0.000 pp | 0.00% +0.001 pp | USD3.50 +1.7% | 2 qtrs — |
| 67 | NEWEDGE ADVISORS, LLC | 31.2K -11.7K (-27.4%) | 111.0K -38.8K (-25.9%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD3.49 +2.0% | 2 qtrs — |
| 68 | MANGROVE PARTNERS | 30.6K +30.6K (+100.0%) | 108.9K +108.9K (+100.0%) | 0.00% +0.003 pp | 0.01% +0.009 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 69 | AQUATIC CAPITAL MANAGEMENT LLC | 29.6K +29.6K (+100.0%) | 105.3K +105.3K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.003 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 70 | HOLT CAPITAL ADVISORS, L.L.C. DBA HOLT CAPITAL PARTNERS, L.P. | 29.5K +29.5K (+100.0%) | 105.1K +105.1K (+100.0%) | 0.00% +0.003 pp | 0.01% +0.014 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 71 | JUMP FINANCIAL, LLC | 25.3K -58.1K (-69.7%) | 90.0K -201.1K (-69.1%) | 0.00% -0.006 pp | 0.00% -0.002 pp | USD3.49 +2.0% | 2 qtrs — |
| 72 | CETERA INVESTMENT ADVISERS | 24.3K -21.0K (-46.3%) | 86.5K -71.4K (-45.2%) | 0.00% -0.002 pp | 0.00% 0.000 pp | USD2.67 +33.3% | 4 qtrs — |
| 73 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 22.5K +19.2K (+585.8%) | 80.0K +68.5K (+599.5%) | 0.00% +0.002 pp | 0.02% +0.012 pp | USD3.55 +0.3% | 2 qtrs — |
| 74 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 21.8K +1.0K (+5.0%) | 77.7K +5.1K (+7.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.12 +67.9% | 3 qtrs — |
| 75 | ENTRYPOINT CAPITAL, LLC | 18.5K +18.5K (+100.0%) | 65.7K +65.7K (+100.0%) | 0.00% +0.002 pp | 0.03% +0.026 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 76 | INTECH INVESTMENT MANAGEMENT LLC | 17.7K -1.9K (-9.6%) | 63.1K -5.3K (-7.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.05 +73.7% | 3 qtrs — |
| 77 | NATIONAL BANK OF CANADA /FI/ | 17.7K -73.7K (-80.6%) | 63.0K -257.1K (-80.3%) | 0.00% -0.008 pp | 0.00% 0.000 pp | USD2.29 +55.5% | 3 qtrs — |
| 78 | SG AMERICAS SECURITIES, LLC | 16.1K -12.2K (-43.1%) | 57.0K -42.0K (-42.4%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD3.49 +2.0% | 2 qtrs — |
| 79 | ADVISER INVESTMENTS LLC | 15.6K +15.6K (+100.0%) | 55.7K +55.7K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.001 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 80 | ENGINEERS GATE MANAGER LP | 15.4K +15.4K (+100.0%) | 54.9K +54.9K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.001 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 81 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 15.4K +— (+0.0%) | 54.8K +1.1K (+2.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.05 +73.7% | 3 qtrs — |
| 82 | BNP PARIBAS ARBITRAGE, SNC | 15.0K +2.9K (+23.6%) | 53.3K +11.0K (+26.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.02 +17.9% | 5 qtrs — |
| 83 | PRUDENTIAL FINANCIAL INC | 14.8K -3.0K (-16.7%) | 52.6K -9.3K (-15.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.49 +2.0% | 2 qtrs — |
| 84 | PROSHARE ADVISORS LLC | 12.5K +2.2K (+21.5%) | 44.4K +8.6K (+24.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.32 +53.4% | 3 qtrs — |
| 85 | VOYA INVESTMENT MANAGEMENT LLC | 11.8K +928.0 (+8.5%) | 42.2K +4.1K (+10.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.17 +64.1% | 3 qtrs — |
| 86 | INTRUA FINANCIAL, LLC | 11.7K -5.7K (-33.0%) | 41.6K -19.2K (-31.6%) | 0.00% -0.001 pp | 0.00% -0.002 pp | USD3.49 +2.0% | 2 qtrs — |
| 87 | R SQUARED LTD | 11.5K +11.5K (+100.0%) | 40.8K +40.8K (+100.0%) | 0.00% +0.001 pp | 0.02% +0.019 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 88 | AMG NATIONAL TRUST BANK | 10.0K +— (+0.0%) | 35.6K +700.0 (+2.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.44 +709.1% | 7 qtrs — |
| 89 | PEKIN HARDY STRAUSS, INC. | 10.0K +10.0K (+100.0%) | 35.6K +35.6K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.003 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 90 | KESTRA ADVISORY SERVICES, LLC | 8.7K +8.7K (+100.0%) | 30.9K +30.9K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD3.56 +0.0% | 1 qtrs NEW |
| 91 | LEGAL & GENERAL GROUP PLC | 7.7K +1.1K (+17.5%) | 27.5K +4.5K (+19.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.27 +56.8% | 3 qtrs — |
| 92 | ADVISOR GROUP HOLDINGS, INC. | 7.0K +4.8K (+215.8%) | 24.9K +17.3K (+226.8%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD3.54 +0.6% | 2 qtrs — |
| 93 | AMERITAS INVESTMENT PARTNERS, INC. | 6.0K +— (+0.0%) | 21.5K +422.0 (+2.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.05 +73.7% | 3 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 44 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Inspire Fidelis Multi Factor ETF FDLS | 1.09% | 2.52M | 0.66% |
| 2 | Invesco Dorsey Wright SmallCap Momentum ETF DWAS | 0.41% | 1.95M | 0.60% |
| 3 | iShares Micro-Cap ETF IWC | 0.10% | 1.51M | 0.60% |
| 4 | Vanguard U.S. Momentum Factor ETF VFMO | 0.09% | 1.50M | 0.13% |
| 5 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.07% | 740.0K | 0.20% |
| 6 | iShares Russell 2000 Growth ETF IWO | 0.02% | 3.25M | 0.24% |
| 7 | Vanguard Russell 2000 Growth ETF VTWG | 0.02% | 346.6K | 0.06% |
| 8 | Fidelity Enhanced Small Cap ETF FESM | 0.02% | 1.04M | 0.28% |
| 9 | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L | 0.02% | 872.2K | 0.30% |
| 10 | iShares Russell 2000 BuyWrite ETF IWMW | 0.01% | 8.2K | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.50
Neutral
Ratio by volume
0.21
Bearish
Buys
1
Sells
2
Shares acquired
20.0K
Shares disposed
95.7K
Cash buys
1.00
Cash sales
2.00
Net activity
-75,719
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | Langsam Jeffrey | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-04-21 | England Kristin | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-04-16 | Kaushal Mohit | Director | S-Sale | D | Common Stock | 38,433 | 3.50 | 134.5K | 172,583 | D | ↗ |
| 2026-04-14 | Kaushal Mohit | Director | S-Sale | D | Common Stock | 57,286 | 3.50 | 200.6K | 211,016 | D | ↗ |
| 2026-04-09 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 20,000 | 3.10 | 62.0K | 10,499,358 | D | ↗ |
| 2026-03-27 | Virnich Daniel | Officer | J-Other | D | Common Stock | 98,534 | 3.07 | 302.5K | 2,360,224 | D | ↗ |
| 2026-03-27 | Podnos Yale | Officer | J-Other | D | Common Stock | 16,173 | 3.07 | 49.7K | 284,783 | D | ↗ |
| 2026-03-27 | Langsam Jeffrey | Officer | A-Award | A | Common Stock | 70,270 | 0.00 | — | 127,650 | D | ↗ |
| 2026-03-27 | England Kristin | Officer | A-Award | A | Common Stock | 55,743 | 0.00 | — | 153,780 | D | ↗ |
| 2026-03-27 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 27,429 | 2.96 | 81.2K | 10,479,358 | D | ↗ |
| 2026-03-27 | Carter Robert Ross | Officer | A-Award | D | Common Stock | 202,914 | 0.00 | — | 436,725 | D | ↗ |
| 2026-03-26 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 50,000 | 3.15 | 157.5K | 10,451,929 | D | ↗ |
| 2026-03-24 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 125,000 | 3.11 | 388.8K | 10,401,929 | D | ↗ |
| 2026-03-20 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 25,000 | 3.35 | 83.8K | 10,276,929 | D | ↗ |
| 2026-03-17 | Virnich Daniel | Officer | J-Other | D | Common Stock | 11,834 | 3.59 | 42.5K | 1,788,150 | D | ↗ |
| 2026-03-17 | Podnos Yale | Officer | J-Other | D | Common Stock | 3,420 | 3.59 | 12.3K | 234,510 | D | ↗ |
| 2026-03-17 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 75,000 | 3.42 | 256.5K | 10,251,929 | D | ↗ |
| 2026-03-17 | Carter Robert Ross | Officer | J-Other | D | Common Stock | 1,314 | 3.59 | 4.7K | 233,811 | D | ↗ |
| 2026-03-16 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 60,985 | 3.29 | 200.6K | 10,176,929 | D | ↗ |
| 2026-03-13 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 263,000 | 2.92 | 768.0K | 10,115,944 | D | ↗ |
| 2026-02-23 | TZOUMAKAS KIMBERLY JO | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-01-02 | STOLPER MARK | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-01-02 | Carter Robert Ross | Officer | J-Other | D | Common Stock | 244 | 3.67 | 895.48 | 235,125 | D | ↗ |
| 2025-12-15 | Hively Brad | Director | S-Sale | D | Common Stock | 13,333 | 3.77 | 50.3K | 683,721 | D | ↗ |
| 2025-12-01 | Ling Gabriel | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-11-20 | Pacala Mark L | Director | A-Award | A | Common Stock | 46,296 | 0.00 | — | 221,267 | D | ↗ |
| 2025-11-20 | McGeorge Anne | Director | A-Award | A | Common Stock | 67,901 | 0.00 | — | 251,247 | D | ↗ |
| 2025-11-20 | Ling Gabriel | Director | A-Award | A | Common Stock | 46,296 | 0.00 | — | 296,502 | D | ↗ |
| 2025-11-20 | Kaushal Mohit | Director | A-Award | A | Common Stock | 50,926 | 0.00 | — | 228,179 | D | ↗ |
| 2025-11-20 | Johnson Karen Marie | Director | A-Award | A | Common Stock | 47,840 | 0.00 | — | 251,249 | D | ↗ |
| 2025-11-20 | Hively Brad | Director | A-Award | A | Common Stock | 41,667 | 0.00 | — | 664,647 | D | ↗ |
| 2025-11-18 | Pacala Mark L | Director | S-Sale | D | Common Stock | 2,160 | 4.00 | 8.6K | 222,811 | D | ↗ |
| 2025-11-18 | M33 Growth I L.P. | Director | J-Other | A | Common Stock | 11,818 | 0.00 | — | 7,944,207 | D | ↗ |
| 2025-11-18 | Ling Gabriel | Director | J-Other | A | Common Stock | 141,149 | 0.00 | — | 250,206 | D | ↗ |
| 2025-11-17 | Virnich Daniel | Officer | A-Award | A | Common Stock | 6,464 | 0.00 | — | 1,799,984 | D | ↗ |
| 2025-11-17 | Podnos Yale | Officer | A-Award | A | Common Stock | 2,086 | 0.00 | — | 237,930 | D | ↗ |
| 2025-11-17 | Carter Robert Ross | Officer | A-Award | A | Common Stock | 195 | 0.00 | — | 235,369 | D | ↗ |
| 2025-11-12 | Virnich Daniel | Officer | A-Award | A | Common Stock | 6,211 | 0.00 | — | 1,793,520 | D | ↗ |
| 2025-11-12 | Podnos Yale | Officer | A-Award | A | Common Stock | 1,202 | 0.00 | — | 235,844 | D | ↗ |
| 2025-09-04 | M33 Growth I L.P. | Director / 10% Owner | S-Sale | D | Common Stock | 6,018,168 | 3.09 | 18.60M | 7,932,389 | D | ↗ |
| 2025-08-19 | Hively Brad | Director | S-Sale | D | Common stock | 20,221 | 4.06 | 82.1K | 622,980 | D | ↗ |
| 2025-08-12 | BARASCH RICHARD A | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-07-24 | BARASCH RICHARD A | Director | J-Other | D | Common Stock | 287,756 | 0.00 | — | 2,635,881 | I | ↗ |
| 2025-07-22 | England Kristin | Officer | A-Award | A | Common Stock | 98,037 | 0.00 | — | 98,037 | D | ↗ |
| 2025-07-07 | England Kristin | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-18 | BARASCH RICHARD A | Director | C-Conversion | A | Common Stock | 620,400 | 0.00 | — | 2,555,541 | I | ↗ |
| 2025-06-17 | BARASCH RICHARD A | Director | C-Conversion | A | Common Stock | 159,500 | 0.00 | — | 1,935,141 | D | ↗ |
| 2025-06-05 | M33 Growth I L.P. | Director / 10% Owner | S-Sale | D | Common Stock | 673,676 | 3.05 | 2.05M | 13,950,557 | D | ↗ |
| 2025-06-03 | Hively Brad | Director | S-Sale | D | Common Stock | 1,867,605 | 2.87 | 5.36M | 712,033 | D | ↗ |
| 2025-05-21 | Virnich Daniel | Officer | D-Return | D | Common stock | 20,388 | 2.68 | 54.5K | 1,787,309 | D | ↗ |
| 2025-05-21 | Podnos Yale | Officer | D-Return | D | Common stock | 1,801 | 2.68 | 4.8K | 234,336 | D | ↗ |
| 2025-05-21 | Langsam Jeffrey | Officer | A-Award | A | Common Stock | 57,380 | 0.00 | — | 57,380 | D | ↗ |
| 2025-05-21 | Castle Jeremy | Officer | D-Return | D | Common stock | 5,636 | 2.68 | 15.1K | 247,031 | D | ↗ |
| 2025-05-21 | Carter Robert Ross | Officer | D-Return | D | Class A Common Stock | 1,601 | 2.68 | 4.3K | 235,174 | D | ↗ |
| 2025-05-20 | M33 Growth I L.P. | Director / 10% Owner | S-Sale | D | Common Stock | 203,532 | 2.71 | 552.2K | 1,349,048 | I | ↗ |
| 2025-05-13 | Langsam Jeffrey | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-31 | Virnich Daniel | Officer | A-Award | A | Common stock | 1,083,334 | 0.00 | — | 1,807,697 | D | ↗ |
| 2025-03-31 | Podnos Yale | Officer | A-Award | A | Common stock | 157,088 | 0.00 | — | 236,137 | D | ↗ |
| 2025-03-31 | Castle Jeremy | Officer | A-Award | A | Common stock | 162,281 | 0.00 | — | 252,667 | D | ↗ |
| 2025-03-31 | Carter Robert Ross | Officer | A-Award | A | Class A Common Stock | 197,368 | 0.00 | — | 236,775 | D | ↗ |
| 2025-03-26 | Virnich Daniel | Officer | P-Purchase | A | Common Warrant | 11,320 | 1.20 | 13.6K | 11,320 | D | ↗ |
| 2025-03-26 | Podnos Yale | Officer | P-Purchase | A | Common Stock | 9,056 | 1.04 | 9.4K | 79,049 | D | ↗ |
| 2025-03-26 | Pacala Mark L | Director | P-Purchase | A | Common Warrant | 42,281 | 1.20 | 50.7K | 42,281 | I | ↗ |
| 2025-03-26 | M33 Growth I L.P. | Director / 10% Owner | A-Award | A | Warrant to Purchase Shares of Common Stock | 1,358,449 | 0.00 | — | 1,358,449 | D | ↗ |
| 2025-03-26 | Johnson Karen Marie | Director | P-Purchase | A | Common Warrant | 18,112 | 1.20 | 21.7K | 18,112 | D | ↗ |
| 2025-03-26 | Hively Brad | Director | P-Purchase | A | Common Stock | 9,056 | 1.04 | 9.4K | 675,809 | D | ↗ |
| 2025-03-26 | Castle Jeremy | Officer | P-Purchase | A | Common Stock | 9,056 | 1.04 | 9.4K | 90,386 | D | ↗ |
| 2025-03-26 | Carter Robert Ross | Officer | P-Purchase | A | Common Warrant | 4,528 | 1.20 | 5.4K | 4,528 | D | ↗ |
| 2025-03-26 | BARASCH RICHARD A | Director | P-Purchase | A | Common Stock | 1,358,448 | 1.04 | 1.42M | 1,775,641 | I | ↗ |
| 2025-03-19 | Virnich Daniel | Officer | D-Return | D | Common stock | 10,261 | 0.89 | 9.1K | 701,723 | D | ↗ |
| 2025-03-19 | Podnos Yale | Officer | D-Return | D | Common stock | 2,975 | 0.89 | 2.6K | 69,993 | D | ↗ |
| 2025-03-19 | Carter Robert Ross | Officer | D-Return | D | Class A Common Stock | 1,150 | 0.89 | 1.0K | 30,351 | D | ↗ |
| 2025-01-06 | Carter Robert Ross | Officer | D-Return | D | Class A Common Stock | 258 | 0.34 | 86.43 | 31,501 | D | ↗ |
| 2024-12-03 | Castle Jeremy | Officer | D-Return | D | Common stock | 1,130 | 0.16 | 180.80 | 81,330 | D | ↗ |
| 2024-12-02 | Hively Brad | Director | P-Purchase | A | Common stock | 50,000 | 0.15 | 7.5K | 666,753 | D | ↗ |
| 2024-11-26 | Hively Brad | Director | P-Purchase | A | Common stock | 250,000 | 0.17 | 42.5K | 616,753 | D | ↗ |
| 2024-11-22 | Pacala Mark L | Director | A-Award | A | Common stock | 50,000 | 0.00 | — | 134,409 | D | ↗ |
| 2024-11-22 | McGeorge Anne | Director | A-Award | A | Common stock | 56,000 | 0.00 | — | 183,346 | D | ↗ |
| 2024-11-22 | Ling Gabriel | Director | A-Award | A | Common stock | 40,000 | 0.00 | — | 109,057 | D | ↗ |
| 2024-11-22 | Kaushal Mohit | Director | A-Award | A | Common stock | 56,000 | 0.00 | — | 177,253 | D | ↗ |
| 2024-11-22 | Johnson Karen Marie | Director | A-Award | A | Common stock | 52,000 | 0.00 | — | 167,185 | D | ↗ |
| 2024-11-22 | Hively Brad | Director | A-Award | A | Common stock | 44,000 | 0.00 | — | 720,203 | D | ↗ |
| 2024-11-22 | BARASCH RICHARD A | Director | A-Award | A | Common stock | 80,000 | 0.00 | — | 417,193 | D | ↗ |
| 2024-11-20 | Virnich Daniel | Officer | D-Return | D | Common stock | 4,977 | 0.14 | 676.87 | 711,984 | D | ↗ |
| 2024-11-20 | Podnos Yale | Officer | D-Return | D | Common stock | 1,026 | 0.14 | 139.54 | 72,968 | D | ↗ |
| 2024-11-20 | Carter Robert Ross | Officer | D-Return | D | Class A Common Stock | 235 | 0.14 | 31.96 | 31,759 | D | ↗ |
| 2024-11-12 | Virnich Daniel | Officer | J-Other | D | Common stock | 78,094 | 0.00 | — | 838,853 | D | ↗ |
| 2024-11-12 | Podnos Yale | Officer | J-Other | D | Common stock | 11,359 | 0.00 | — | 93,009 | D | ↗ |
| 2024-11-12 | Pacala Mark L | Director | J-Other | D | Common stock | 20,248 | 0.00 | — | 114,781 | D | ↗ |
| 2024-11-12 | Hively Brad | Director | J-Other | D | Common stock | 353,450 | 0.00 | — | 366,753 | D | ↗ |
| 2024-09-20 | Carter Robert Ross | Officer | — | — | Common Stock | 0 | 0.00 | — | 1,161 | D | ↗ |
| 2024-08-16 | Havencrest Healthcare Partners, L.P. | 10% Owner | J-Other | D | Common stock | 8,701,823 | 0.00 | — | 7,884,044 | — | ↗ |
| 2024-06-17 | Hively Brad | Director | D-Return | D | Common Stock | 18,121 | 0.46 | 8.3K | 676,203 | — | ↗ |
| 2024-05-22 | Hively Brad | Director | D-Return | D | Common Stock | 19,526 | 0.58 | 11.2K | 694,324 | — | ↗ |
| 2024-05-21 | Virnich Daniel | Officer | D-Return | D | Common Stock | 11,173 | 0.60 | 6.7K | 718,430 | — | ↗ |
| 2024-05-21 | Shah Mihir | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 378,648 | 2.00 | 757.3K | 378,648 | — | ↗ |
| 2024-05-21 | Podnos Yale | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 43,825 | 2.00 | 87.7K | 43,825 | — | ↗ |
| 2024-05-21 | Castle Jeremy | Officer | A-Award | A | Common Stock | 70,120 | 0.00 | — | 82,460 | — | ↗ |
| 2024-01-29 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 8,637 | 2.12 | 18.3K | 0 | — | ↗ |
| 2024-01-26 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 6,979 | 2.14 | 14.9K | 8,637 | — | ↗ |
| 2024-01-25 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 11,882 | 2.07 | 24.6K | 15,616 | — | ↗ |
| 2024-01-24 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 24,915 | 2.30 | 57.3K | 27,498 | — | ↗ |
| 2024-01-23 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 5,338 | 2.11 | 11.3K | 52,413 | — | ↗ |
| 2024-01-22 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 10,263 | 2.12 | 21.8K | 57,751 | — | ↗ |
| 2024-01-19 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 11,986 | 2.13 | 25.5K | 68,014 | — | ↗ |
| 2023-12-28 | Havencrest Healthcare Partners, L.P. | 10% Owner | J-Other | D | Common stock | 4,561,050 | 0.00 | — | 12,801,821 | — | ↗ |
| 2023-12-26 | Pacala Mark L | Director | A-Award | A | Common stock | 46,630 | 0.00 | — | 135,029 | — | ↗ |
| 2023-12-26 | O'Meara Maeve | Director | A-Award | A | Common stock | 50,000 | 0.00 | — | 109,104 | — | ↗ |
| 2023-12-26 | McGeorge Anne | Director | A-Award | A | Common stock | 56,000 | 0.00 | — | 127,346 | — | ↗ |
| 2023-12-26 | Ling Gabriel | Director | A-Award | A | Common stock | 40,000 | 0.00 | — | 69,057 | — | ↗ |
| 2023-12-26 | Kaushal Mohit | Director | A-Award | A | Common stock | 53,326 | 0.00 | — | 121,253 | — | ↗ |
| 2023-12-26 | Johnson Karen Marie | Director | A-Award | A | Common stock | 52,000 | 0.00 | — | 115,185 | — | ↗ |
| 2023-12-26 | Hively Brad | Director | A-Award | A | Common stock | 42,652 | 0.00 | — | 713,850 | — | ↗ |
| 2023-12-26 | BARASCH RICHARD A | Director | A-Award | A | Common stock | 80,000 | 0.00 | — | 337,193 | — | ↗ |
| 2023-12-14 | Shah Mihir | Officer | P-Purchase | A | Common stock | 565 | 1.25 | 706.25 | 328,122 | — | ↗ |
| 2023-11-30 | Castle Jeremy | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 30,849 | 1.71 | 52.8K | 30,849 | — | ↗ |
| 2023-11-21 | Virnich Daniel | Officer | D-Return | D | Common stock | 4,322 | 2.19 | 9.5K | 729,603 | — | ↗ |
| 2023-11-21 | Podnos Yale | Officer | D-Return | D | Common stock | 1,530 | 2.19 | 3.4K | 86,838 | — | ↗ |
| 2023-11-21 | Hively Brad | Director | D-Return | D | Common stock | 25,867 | 2.19 | 56.7K | 671,198 | — | ↗ |
| 2023-11-17 | Hively Brad | Director | S-Sale | D | Common stock | 25,000 | 2.24 | 56.0K | 697,065 | — | ↗ |
| 2023-11-14 | Virnich Daniel | Officer | D-Return | D | Common stock | 4,604 | 2.39 | 11.0K | 733,925 | — | ↗ |
| 2023-11-14 | Podnos Yale | Officer | D-Return | D | Common stock | 238 | 2.39 | 567.87 | 90,228 | — | ↗ |
| 2023-11-14 | Hively Brad | Director | D-Return | D | Common stock | 27,117 | 2.39 | 64.8K | 697,065 | — | ↗ |
| 2023-11-13 | Hively Brad | Director | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 47,000 | 0.85 | 40.0K | 1,770,431 | — | ↗ |
| 2023-09-05 | Castle Jeremy | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-05-23 | Shah Mihir | Officer | D-Return | D | Common Stock | 869 | 0.43 | 371.93 | 223,472 | — | ↗ |
| 2023-03-17 | Virnich Daniel | Officer | A-Award | A | Common stock | 114,944 | 0.00 | — | 738,529 | — | ↗ |
| 2023-03-17 | Shah Mihir | Officer | A-Award | A | Common stock | 176,191 | 0.00 | — | 226,914 | — | ↗ |
| 2023-03-17 | SARIN RAVI YANG | Director | A-Award | A | Common stock | 29,528 | 0.00 | — | 75,427 | — | ↗ |
| 2023-03-17 | Podnos Yale | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 83,047 | 0.48 | 39.9K | 83,047 | — | ↗ |
| 2023-03-17 | Pacala Mark L | Director | A-Award | A | Common stock | 6,562 | 0.00 | — | 88,399 | — | ↗ |
| 2023-03-17 | O'Meara Maeve | Director | A-Award | A | Common stock | 16,404 | 0.00 | — | 59,104 | — | ↗ |
| 2023-03-17 | Miller Matthew P | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 169,169 | 0.48 | 81.4K | 169,169 | — | ↗ |
| 2023-03-17 | McGeorge Anne | Director | A-Award | A | Common stock | 26,247 | 0.00 | — | 71,346 | — | ↗ |
| 2023-03-17 | Kaushal Mohit | Director | A-Award | A | Common stock | 19,685 | 0.00 | — | 42,393 | — | ↗ |
| 2023-03-17 | Johnson Karen Marie | Director | A-Award | A | Common stock | 19,685 | 0.00 | — | 63,185 | — | ↗ |
| 2023-03-17 | Hively Brad | Director / Officer | A-Award | A | Common stock | 168,512 | 0.00 | — | 724,182 | — | ↗ |
| 2023-03-17 | BARASCH RICHARD A | Director | P-Purchase | A | Common stock | 200 | 0.55 | 109.60 | 217,445 | — | ↗ |
| 2022-12-16 | Miller Matthew P | Officer | P-Purchase | A | Common Stock | 73,684 | 0.95 | 70.0K | 175,325 | — | ↗ |
| 2022-12-07 | Virnich Daniel | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 175,000 | 0.00 | — | 829,609 | — | ↗ |
| 2022-11-17 | Virnich Daniel | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 203,543 | 0.00 | — | 203,543 | — | ↗ |
| 2022-11-17 | Simoneit Diona | Officer | A-Award | A | Common Stock | 10,387 | 0.00 | — | 39,705 | — | ↗ |
| 2022-11-17 | Shah Mihir | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 94,418 | 0.00 | — | 94,418 | — | ↗ |
| 2022-11-17 | SARIN RAVI YANG | Director | A-Award | A | Common Stock | 22,708 | 0.00 | — | 45,899 | — | ↗ |
| 2022-11-17 | Podnos Yale | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 71,895 | 0.00 | — | 71,895 | — | ↗ |
| 2022-11-17 | Pacala Mark L | Director | A-Award | A | Common Stock | 29,057 | 0.00 | — | 81,837 | — | ↗ |
| 2022-11-17 | O'Meara Maeve | Director | A-Award | A | Common Stock | 22,708 | 0.00 | — | 42,700 | — | ↗ |
| 2022-11-17 | Miller Matthew P | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 119,825 | 0.00 | — | 119,825 | — | ↗ |
| 2022-11-17 | McGeorge Anne | Director | A-Award | A | Common Stock | 22,708 | 0.00 | — | 45,099 | — | ↗ |
| 2022-11-17 | Ling Gabriel | Director | A-Award | A | Common Stock | 29,057 | 0.00 | — | 29,057 | — | ↗ |
| 2022-11-17 | Kaushal Mohit | Director | A-Award | A | Common Stock | 22,708 | 0.00 | — | 48,242 | — | ↗ |
| 2022-11-17 | Johnson Karen Marie | Director | A-Award | A | Common Stock | 22,708 | 0.00 | — | 43,500 | — | ↗ |
| 2022-11-17 | Hively Brad | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 525,188 | 0.00 | — | 525,188 | — | ↗ |
| 2022-11-17 | BARASCH RICHARD A | Director | A-Award | A | Common Stock | 22,708 | 0.00 | — | 164,727 | — | ↗ |
| 2022-11-15 | Virnich Daniel | Officer | D-Return | D | Common Stock | 3,767 | 2.03 | 7.6K | 233,484 | — | ↗ |
| 2022-11-15 | Simoneit Diona | Officer | D-Return | D | Common Stock | 190 | 2.03 | 385.28 | 29,318 | — | ↗ |
| 2022-11-15 | Podnos Yale | Officer | D-Return | D | Common Stock | 199 | 2.03 | 403.51 | 43,083 | — | ↗ |
| 2022-11-15 | Miller Matthew P | Officer | D-Return | D | Common Stock | 577 | 2.03 | 1.2K | 78,034 | — | ↗ |
| 2022-11-15 | Hively Brad | Officer | D-Return | D | Common Stock | 9,718 | 2.03 | 19.7K | 452,201 | — | ↗ |
| 2022-11-14 | Kaushal Mohit | Director | S-Sale | D | Common Stock | 15,994 | 2.13 | 34.1K | 25,534 | — | ↗ |
| 2022-11-11 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 365,321 | 2.33 | 851.2K | 13,362,873 | — | ↗ |
| 2022-11-10 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 61,281 | 2.98 | 182.6K | 13,728,194 | — | ↗ |
| 2022-11-09 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 80,000 | 3.09 | 247.2K | 13,789,475 | — | ↗ |
| 2022-11-08 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 27,000 | 3.24 | 87.5K | 13,869,475 | — | ↗ |
| 2022-11-07 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 19,167 | 3.28 | 62.9K | 13,896,475 | — | ↗ |
| 2022-11-04 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 50,200 | 3.39 | 170.2K | 13,915,642 | — | ↗ |
| 2022-11-03 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 45,500 | 3.58 | 162.9K | 13,965,842 | — | ↗ |
| 2022-11-02 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 58,500 | 3.94 | 230.5K | 14,011,342 | — | ↗ |
| 2022-11-01 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 50,272 | 4.26 | 214.2K | 14,069,842 | — | ↗ |
| 2022-10-31 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 41,855 | 4.69 | 196.3K | 14,120,114 | — | ↗ |
| 2022-10-28 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 52,091 | 4.84 | 252.1K | 14,161,969 | — | ↗ |
| 2022-10-27 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 35,000 | 5.09 | 178.2K | 14,214,060 | — | ↗ |
| 2022-10-26 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 52,500 | 5.16 | 270.9K | 14,249,060 | — | ↗ |
| 2022-10-25 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 30,400 | 5.10 | 155.0K | 14,301,560 | — | ↗ |
| 2022-10-24 | Kaushal Mohit | Director | S-Sale | D | Common stock | 4,798 | 4.96 | 23.8K | 41,528 | — | ↗ |
| 2022-10-24 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 29,400 | 4.98 | 146.4K | 14,331,960 | — | ↗ |
| 2022-10-21 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 20,000 | 4.96 | 99.2K | 14,361,360 | — | ↗ |
| 2022-10-20 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 12,000 | 4.83 | 58.0K | 14,381,360 | — | ↗ |
| 2022-10-19 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 17,500 | 4.68 | 81.9K | 14,393,360 | — | ↗ |
| 2022-10-18 | Havencrest Healthcare Partners, L.P. | Director | S-Sale | D | Common stock | 12,200 | 4.63 | 56.5K | 14,410,860 | — | ↗ |
| 2022-10-17 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 8,249 | 4.60 | 37.9K | 14,423,060 | — | ↗ |
| 2022-10-14 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 9,800 | 4.54 | 44.5K | 14,431,309 | — | ↗ |
| 2022-10-13 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 25,200 | 4.67 | 117.7K | 14,441,109 | — | ↗ |
| 2022-10-12 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 14,343 | 4.70 | 67.4K | 14,466,309 | — | ↗ |
| 2022-10-11 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 25,000 | 4.66 | 116.5K | 14,480,652 | — | ↗ |
| 2022-10-10 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 21,500 | 4.33 | 93.1K | 14,505,652 | — | ↗ |
| 2022-10-07 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 14,652 | 4.63 | 67.8K | 14,527,152 | — | ↗ |
| 2022-10-06 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 33,509 | 4.45 | 149.1K | 14,541,804 | — | ↗ |
| 2022-10-05 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 14,060 | 4.78 | 67.2K | 14,575,313 | — | ↗ |
| 2022-10-05 | BARASCH RICHARD A | Director | J-Other | A | Private Placement Warrants | 548,503 | 0.00 | — | 548,503 | — | ↗ |
| 2022-10-04 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 23,447 | 4.85 | 113.7K | 14,589,373 | — | ↗ |
| 2022-10-03 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 16,765 | 4.72 | 79.1K | 14,612,820 | — | ↗ |
| 2022-09-30 | TOI HC I, LLC | Director | S-Sale | D | Common stock | 11,000 | 4.68 | 51.5K | 14,629,585 | — | ↗ |
| 2022-09-29 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 21,000 | 4.62 | 97.0K | 14,640,585 | — | ↗ |
| 2022-09-28 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 12,642 | 4.72 | 59.7K | 14,661,585 | — | ↗ |
| 2022-09-27 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 14,074 | 4.69 | 66.0K | 14,674,227 | — | ↗ |
| 2022-09-26 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 7,153 | 4.57 | 32.7K | 14,688,301 | — | ↗ |
| 2022-09-23 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 5,375 | 4.19 | 22.5K | 14,695,454 | — | ↗ |
| 2022-09-22 | Havencrest Healthcare Partners, L.P. | 10% Owner | S-Sale | D | Common stock | 13,086 | 4.25 | 55.6K | 14,700,829 | — | ↗ |
| 2022-09-21 | Pacala Mark L | Director | — | D | Common stock | 0 | 0.00 | — | 30,372 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-43.7K
Shares Outstanding
98.84M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Daniel Virnich | 475.0K | 212.7K | 1.24M | — | — | 12.2K | 1.93M | 63.83% | ↗ |
| 2 | 2025 | Yale Podnos | 447.0K | 137.6K | 179.1K | — | — | 12.2K | 775.9K | 23.08% | ↗ |
| 3 | 2025 | Robert Carter | 390.0K | 106.9K | 225.0K | — | — | 12.2K | 734.1K | 30.65% | ↗ |
| 4 | 2024 | Daniel Virnich | 475.0K | 217.1K | 118.3K | 295.8K | — | 12.2K | 1.12M | 37.03% | ↗ |
| 5 | 2024 | Yale Podnos | 407.0K | 154.6K | 10.4K | 26.1K | — | 12.2K | 610.3K | 5.99% | ↗ |
| 6 | 2024 | Robert Carter | 288.8K | 101.0K | 9.3K | 23.2K | — | 12.2K | 434.4K | 7.48% | ↗ |
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daniel Virnich FACHE | Chief Executive Officer & Executive Director | 699.9K | — |
| Yale D. Podnos | Chief Medical Officer | 573.8K | — |
| Robert Carter | Chief Financial Officer | 505.1K | male |
| Mark Hueppelsheuser | General Counsel | — | male |
| Austin Lee | Vice President of Accounting & Controller | — | male |
| Nolan Mariano | Chief People Officer | — | male |
| Rakesh Panda | Chief Information Officer | — | male |
| Stephen Cella | Senior Vice President of Finance | — | male |
| Minh Merchant | Chief Legal Officer | — | female |
| Jordan McInerney | Chief Development Officer | — | male |
| Kristin England | Chief Administrative Officer | — | female |
ESG Rating
ESG Score History MEDICAL - CARE FACILITIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TOI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
